She has tried every type of cream and states its an under skin type of rash. Sometimes it makes her bleed; ever since the first shot, she has been very itchy, states its an under skin type of rash.; This spontaneous case was reported by a patient and describes the occurrence of PURPURA (She has tried every type of cream and states its an under skin type of rash. Sometimes it makes her bleed) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Diverticulitis (Mild case, 10 years ago, better in a couple of days.). Concurrent medical conditions included Seasonal allergy (patient was receiving allergies shots.) and Hashimoto's disease since 2014.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced RASH PRURITIC (ever since the first shot, she has been very itchy, states its an under skin type of rash.). On an unknown date, the patient experienced PURPURA (She has tried every type of cream and states its an under skin type of rash. Sometimes it makes her bleed) (seriousness criterion medically significant). At the time of the report, PURPURA (She has tried every type of cream and states its an under skin type of rash. Sometimes it makes her bleed) and RASH PRURITIC (ever since the first shot, she has been very itchy, states its an under skin type of rash.) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Skin test: symptoms looks like 'long-covid' symptoms looks like 'long-Covid'.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient never had COVID positive test or diagnosis. No other vaccines were given within 1 month prior to Moderna COVID-19 vaccine. No concomitant drug was reported. The patient did not experience the similar events in the past. The patient went to the allergist and they did a patch test. The allergist said the symptoms looks like "long-Covid. The patient stated she never had the virus. Symptoms and outcome for the events were reported as worsened. The patient had tried every type of cream and antihistamine nothing was happening. The patent would be going to dermatologist.  Company Comment: This is a spontaneous case concerns a female patient of an unknown age with a relevant medical history of Seasonal allergy, who experienced the unexpected serious (medically significant) AESI of Purpura and non-serious event of Rash pruritic unspecified days after the first dose of mRNA-1273 vaccine. Its reported that after the first dose of vaccination she has been very itchy, states its an under skin type of rash and sometimes its bleeding. The patient went to the allergist and they did a patch test and said the symptoms looks like long-Covid. The patient had tried every type of cream and antihistamine nothing was happening. Patients relevant medical history of Seasonal allergy could be contributory to the events. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   This case was linked to MOD-2022-568601.   Reporter did not allow further contact; Sender's Comments: This is a spontaneous case concerns a female patient of an unknown age with a relevant medical history of Seasonal allergy, who experienced the unexpected serious (medically significant) AESI of Purpura and non-serious event of Rash pruritic unspecified days after the first dose of mRNA-1273 vaccine. Its reported that after the first dose of vaccination she has been very itchy, states its an under skin type of rash and sometimes its bleeding. The patient went to the allergist and they did a patch test and said the symptoms looks like long-Covid. The patient had tried every type of cream and antihistamine nothing was happening. Patients relevant medical history of Seasonal allergy could be contributory to the events. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.